Defense Secretary Pete Hegseth announced an initiative to screen military service members age 30 and older for testosterone levels annually, with hormone replacement therapy offered as a voluntary option for those who test low. Hegseth described the program as supporting the health and readiness of troops, while a Democratic lawmaker criticized it, and some outlets and a medical expert raised questions about the underlying science and motivations behind the plan.
The New York Times and Vox frame the policy as part of Hegseth's effort to project a 'macho' or 'manosphere-friendly' image, with Vox explicitly arguing the science does not support the initiative's premise ('Testosterone shots won't help'), casting doubt on the program's medical justification and connecting it to Hegseth's broader gender-culture agenda.
BBC News covers the announcement straightforwardly, quoting Hegseth and Pentagon spokesman Parnell, adding medical context from an FDA panel expert on testosterone's health effects and risks, noting Democratic criticism, and linking the move to broader RFK Jr./FDA efforts to loosen testosterone prescribing rules. The NPR item is a quiz blurb with no substantive framing.
The Daily Wire and Breitbart present the announcement neutrally to favorably, relaying Hegseth's own framing at length -- readiness, warfighter health, voluntary treatment, and long-term care for troops -- without raising skepticism about motives or science.